Autoimmune diagnostics Market is estimated to reach $15.6 billion by 2021
The Global Autoimmune diagnostics Market was worth $13.07 billion in 2016 and estimated to reach $15.6 billion by the end of 2021 with a growing potential of 3.6%. Autoimmune disease is a disorder where the patient’s immune system attacks own body tissues that led to the damage of body organs.
Nearly 80 types of autoimmune diseases are known so far.
The Global Auto immune diagnostics market is expected to show tremendous growth due to Mergers & acquisitions between research institutes and the companies.
Increasing advancements in new technologies and services are expected to increase the Point of care tests which will change the dynamics of the market over the forecast period. The most common autoimmune diseases include Graves’ disease, rheumatoid arthritis, Hashimoto’s thyroiditis, type1 diabetes, multiple sclerosis and systemic lupus erythematosus.
Full report at: www.marketdataforecast.com/market-…tics-market-1190/
Recent discoveries in auto immune disease diagnostic techniques, upgraded laboratory techniques, increasing public awareness for autoimmune disorders and automation are the major factors driving the growth of the market. The key restraints that inhibiting the growth of the auto immune diagnostics market are Competitive pricing among the major manufacturers, unavailability of skilled manpower and growing demand for innovative technological products.
The Global Auto immune diagnostics Market is broadly categorized based on Test type into Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others.
Based on Disease type the market is categorized into Localized auto immune disease diagnostics and systemic auto immune disease diagnostics. Local auto immune disease diagnostics is further classified into Graves’ disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others.
Systemic auto immune disease diagnostics is categorized into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Ankylosing Spondylitis. The occurrence of rheumatoid arthritis is the highest since it can occur at any age.
Rheumatoid arthritis has therefore accounts for the largest segment in the autoimmune disease diagnostics market, based on disease type.
- By Product Type
- By Technology
- End User
Based on End users into Hospitals, Research centers, and diagnostic laboratories and on the basis of geography, the Auto immune Diagnostics market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America dominates the global autoimmune diagnostics market with highest share followed by Europe, Asia - Pacific.
Asia-Pacific market is expected to account highest growth during the forecast period.
Some of the major companies dominating the global Auto immune disease market by their products and services include Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: